Fresenius SE

Business & Finance - 2008

30.09.2008Syndicated Credit Facilities for APP Pharmaceuticals acquisition financing increased by US$ 500 million due to strong demand
PDF Text as PDF-file
16.09.2008Fresenius Medical Care Announces Closing of the U.S. License Agreement for Intravenous Iron Products
PDF Text as PDF-file
10.09.2008Fresenius closes APP acquisition
PDF Text as PDF-file
02.09.2008Fresenius and APP Pharmaceuticals Announce Clearance of APP Acquisition by U.S. Federal Trade Commission
PDF Text as PDF-file
28.08.2008Moody’s confirms Fresenius SE’s Ba1 rating
PDF Text as PDF-file
12.08.2008Fresenius SE successfully completes capital increase
PDF Text as PDF-file
11.08.2008Acquisition of Dabur Pharma successfully closed
PDF Text as PDF-file
11.08.2008Substantial oversubscription in first phase of syndication of US$ 2,400 million Senior Secured Credit Facilities
PDF Text as PDF-file
11.08.2008Fresenius resolves on capital increase
PDF Text as PDF-file
17.07.2008Issuance of mandatory exchangeable bonds, exchangeable into ordinary shares of Fresenius Medical Care AG & Co. KGaA
PDF Text as PDF-file
17.07.2008Fresenius SE successfully executes offering of € 554 million mandatory exchangeable bonds, exchangeable into ordinary shares of Fresenius Medical Care
PDF Text as PDF-file
09.07.2008Fresenius Medical Care Signs Agreements for Intravenous Iron Products
PDF Text as PDF-file
07.07.2008Fresenius Kabi to acquire APP Pharmaceuticals – entry into North American I.V. generics market provides excellent growth opportunities
PDF Text as PDF-file
06.06.2008Fresenius Group donates over US$ 1.5 million in aid for victims of earthquake in China
PDF Text as PDF-file
21.05.2008Annual General Meeting of Fresenius SE: Fresenius Confirms Positive Outlook for 2008 – 15th Consecutive Dividend Increase Approved
20.05.2008Moody's Rating of Fresenius Medical Care AG & Co. KGaA upgraded to Ba1
PDF Text as PDF-file
20.05.2008Moody’s upgrades rating of Fresenius SE to Ba1
PDF Text as PDF-file
20.05.2008Fresenius Medical Care Reports Strong Start for 2008 - Shareholders Approve Eleventh Consecutive Annual Dividend Increase
PDF Text as PDF-file
20.04.2008Fresenius Kabi strengthens its position in i.v. drugs by acquiring Dabur Pharma, a leading manufacturer of oncology generics
PDF Text as PDF-file
07.04.2008Fresenius Medical Care announces status in Patent Case
PDF Text as PDF-file
02.04.2008Fresenius Medical Care Announces upgraded Rating of Unsecured Debt Issues by Standard & Poor’s
PDF Text as PDF-file
06.03.2008Fresenius Medical Care Expands Dialyzer Production Capacity at St. Wendel, Germany
PDF Text as PDF-file
29.01.2008Portugal to Introduce a Bundled Rate for Hemodialysis Treatment
PDF Text as PDF-file
25.01.2008Fresenius Medical Care Extends Senior Note Exchange Offer
PDF Text as PDF-file
11.01.2008Fresenius Medical Care Selected To Provide Dialysis Care to More than 400 Patients in the U.K.
PDF Text as PDF-file
Home  >  Press  >  Press Releases  >  Business & Finance  >  2008